We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
-3.31%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$18.5B
AUM Growth
+$95.7M
Cap. Flow
+$1.16B
Cap. Flow %
6.27%
Top 10 Hldgs %
26.36%
Holding
2,855
New
45
Increased
464
Reduced
2,118
Closed
74

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$179M
2
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$98.7M
3
KD icon
Kyndryl
KD
+$21.8M
4
MRCY icon
Mercury Systems
MRCY
+$20.2M
5
ZION icon
Zions Bancorporation
ZION
+$19.9M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$33.8M
2
AAPL icon
Apple
AAPL
+$29.5M
3
NVDA icon
NVIDIA
NVDA
+$27.4M
4
MSFT icon
Microsoft
MSFT
+$26.2M
5
META icon
Meta Platforms (Facebook)
META
+$17.4M

Sector Composition

Rank Sector Weight
1 Technology 26.11%
2 Financials 14.21%
3 Healthcare 11%
4 Consumer Discretionary 10.49%
5 Industrials 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INZY
2801
DELISTED
Inozyme Pharma
INZY
– –
-23,958
Closed -$66.4K
IRBT
2802
DELISTED
iRobot
IRBT
– –
-12,212
Closed -$94.6K
JILL icon
2803
J. Jill
JILL
$279M
– –
-3,466
Closed -$95.7K
JOUT icon
2804
Johnson Outdoors
JOUT
$499M
– –
-2,918
Closed -$96.3K
JSPR icon
2805
Jasper Therapeutics
JSPR
$27.4M
– –
-6,874
Closed -$147K
KOD icon
2806
Kodiak Sciences
KOD
$2.72B
– –
-21,040
Closed -$209K
LRMR icon
2807
Larimar Therapeutics
LRMR
$454M
– –
-18,428
Closed -$71.3K
LXEO icon
2808
Lexeo Therapeutics
LXEO
$382M
– –
-14,223
Closed -$93.6K
MRSN
2809
DELISTED
Mersana Therapeutics
MRSN
– –
-2,926
Closed -$105K
MYPS icon
2810
PLAYSTUDIOS Inc
MYPS
$72.1M
– –
-58,345
Closed -$109K
NMRA icon
2811
Neumora Therapeutics
NMRA
$317M
– –
-52,243
Closed -$554K
NNBR icon
2812
NN Inc
NNBR
$302M
– –
-27,181
Closed -$88.9K
NOVA
2813
DELISTED
Sunnova Energy
NOVA
– –
-42,730
Closed -$147K
NPWR icon
2814
NET Power
NPWR
$144M
– –
-12,922
Closed -$137K
NRGV icon
2815
Energy Vault
NRGV
$710M
– –
-37,737
Closed -$86K
PEBK icon
2816
Peoples Bancorp of North Carolina
PEBK
$239M
– –
-2,711
Closed -$84.7K
PLRX icon
2817
Pliant Therapeutics
PLRX
$66.3M
– –
-36,788
Closed -$484K
PRME icon
2818
Prime Medicine
PRME
$580M
– –
-25,031
Closed -$73.1K
PROK icon
2819
ProKidney
PROK
$304M
– –
-7,918
Closed -$13.4K
LNAI
2820
Lunai Bioworks
LNAI
$10.7M
– –
-943
Closed -$63K
SERA icon
2821
Sera Prognostics
SERA
$79.1M
– –
-17,254
Closed -$140K
SPCE icon
2822
Virgin Galactic
SPCE
$500M
– –
-16,578
Closed -$97.5K
STRO icon
2823
Sutro Biopharma
STRO
$353M
– –
-2,339
Closed -$43K
THRD
2824
DELISTED
Third Harmonic Bio
THRD
– –
-12,859
Closed -$132K
TNGX icon
2825
Tango Therapeutics
TNGX
$4.31B
– –
-19,631
Closed -$60.7K
111 112
113
114 115

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

MetLife Investment Management's Q1 2025 Portfolio in Review

As of Q1 2025, MetLife Investment Management held 2,855 positions worth $18.5B, up 0.52% from $18.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

MetLife Investment Management deployed $1.16B of net new capital in Q1 2025, opening 45 new positions and adding to 464 existing holdings. Its largest new stake was Stevanato: 633,887 shares worth $12.9M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $33.8M trimmed.

  • MetLife Investment Management's largest Q1 2025 buy was Stevanato: 633,887 shares worth $12.9M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $179M increase.
  • MetLife Investment Management's biggest Q1 2025 reduction was iShares MSCI EAFE ETF, cutting an estimated $33.8M.
  • MetLife Investment Management fully exited Altair Engineering Inc in Q1 2025, selling an estimated $7.12M.
  • MetLife Investment Management's ten largest holdings make up 26% of its $18.5B portfolio in Q1 2025.
  • MetLife Investment Management opened 45 new positions and closed 74 in Q1 2025.
  • MetLife Investment Management's portfolio value rose 0.52% quarter-over-quarter to $18.5B.

Based on MetLife Investment Management's 13F filing for Q1 2025, filed 14 May 2025.